SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : qtrn(quintiles trans)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Marty who wrote (46)11/5/1999 5:29:00 PM
From: Ron   of 105
 
A good time to pick up some QTRN, looks to me. Price still low and strengthening position of company/shareholders:
RESEARCH TRIANGLE PARK, N.C., Nov. 5 /PRNewswire/ -- Quintiles Transnational Corp. (Nasdaq: QTRN) announced today that its Board of Directors has adopted a Shareholder Rights Plan designed to give the Board wider authority to evaluate any potential unsolicited attempt to acquire control of
the Company. The plan is not being adopted in response to any specific effort to acquire control of Quintiles, but as a result of ongoing review by the Board. Under the plan, shareholders of Quintiles would receive rights to acquire
additional shares upon the accumulation of 15% or more of the Company's common stock by a third party, subject to exceptions made by Board action.
Details of the plan are contained in a summary, which will be mailed to all Quintiles shareholders of record as of Nov. 15, 1999. The full plan may be accessed on the Securities and Exchange Commission EDGAR database at
www.sec.gov/cgi-bin/srch-edgar
Quintiles Transnational Corp. is the market leader in providing a full range of integrated product development and commercialization solutions to the pharmaceutical, biotechnology and medical device industries. Quintiles also
is a leader in electronic transactions processing and informatics for the healthcare sector and provides healthcare policy consulting to governments and other organizations worldwide.
Headquartered near Research Triangle Park, North Carolina, Quintiles is a member of the Fortune 1000 and the Nasdaq-100 Index. With more than 20,000 employees worldwide and offices in 31 countries, Quintiles operates through
specialized work groups dedicated to meeting customers' individual needs.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext